companies · BE EditionLive
ProteoFormiX
TLDR
ProteoFormiX uses mass spectrometry imaging to identify disease-associated peptides and metabolites in human tissue and biofluid samples for biomarker discovery and diagnosis.
Overview
ProteoFormiX specializes in mass spectrometry imaging analyses, particularly for FFPE pathology samples, employing proprietary technology to detect proteoforms and metabolite sets in clinical specimens. The company aims to transform archived tissue biobanks into resources for disease discovery and diagnosis.
Recent mentions
Filed under